Clinical Trial Update: G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the use of G-CSF to stimulate peripheral blood stem cell collection for autologous stem cell transplantation in patients with chronic p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Filgrastim (filgrastim)
• Neupogen (Filgrastim)

Snippet

Sponsor: Herbert Irving Comprehensive Cancer Center | Conditions: Leukemia | Phase 1 | Status: COMPLETED